Overview
Depending on the location and size of the bleeding, brain hemorrhage may have no symptoms at all. In some cases, doctors will perform an MRI or CT scan to determine if there is a potential bleed inside the brain. Surgical repair may be necessary if the bleeding is too large. Anticonvulsant medications may also be prescribed to prevent post-traumatic seizures. Taking precautions to avoid any possible head injury is essential.
Symptoms of a brain hemorrhage will vary depending on where the bleeding occurs. Some patients will experience vision problems, balance problems, numbness, and sudden seizures. Some patients may experience some or all of these symptoms. Those with a large hemorrhage may experience post-traumatic seizures. After the surgery, the patient will need to stay in the hospital for further evaluation. If symptoms persist, the patient should see a physician right away.
The symptoms of brain hemorrhage vary, and may include problems speaking, walking, and using one side of the body. Some patients may have difficulty walking after the stroke, while others will have only mild symptoms. If the bleeding is not severe, it is possible to regain consciousness. The next steps are physical therapy, occupational therapy, and medication. Some patients may experience speech and vision loss. They should be monitored carefully for at least 2 weeks to rule out other causes of stroke.
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/4659
Market Drivers:
Efficiency in treatment of brain hemorrhage is expected to propel growth of the global brain hemorrhage market over the forecast period. For example, a study published in the Nature Journal in October 2017, reported that intensive blood pressure lowering using anti-hypertensive drugs can result in reduction of hematoma (blood mass) in patients with intracerebral hemorrhage volume less than 15 mL.
Moreover, availability of drugs at affordable cost is also expected to propel growth of the global brain hemorrhage market over the forecast period. For example, the government of India, in August 2019, added Tenectase (tenecteplase), manufactured by Gennova Biopharmaceuticals Limited to the new guidelines for treatment of brain clots, leading to reduction of treatment cost by almost 50% and also giving a boost to indigenous research.
Market Trends:
High incidence of brain hemorrhage is expected to propel growth of the global brain hemorrhage market over the forecast period. For instance, according to an article published by the Journal of Neurosurgery in April 2018, it is estimated that around 500–800 new cases of traumatic brain injury per 100,000 people are reported every year in the U.S. and New Zealand.
Covid-19 Impact Analysis:
Only 0.2% of COVID-19 patients in a study reported intracerebral hemorrhage. Out of these 48 COVID-19 patients, 26 patients were diagnosed for COVID-19 before having intracerebral hemorrhage, 10 patients were diagnosed for COVID-19 on the same day of incidence of intracerebral hemorrhage and six patients were diagnosed for COVID-19 during hospitalization for intracerebral hemorrhage, according to a research study published in Stroke medical journal in June 2021
Key Developments:
Major players operating in the global brain hemorrhage market are focused on adopting merger and acquisition strategies to expand their product portfolio. For example, in January 2020, Atnahs Pharma partnered with AstraZeneca to acquire commercial rights to drugs such as Inderal (propranolol), Tenormin (atenolol), and others.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/4659
Competitive Landscape:
Major players operating in the global brain hemorrhage market include, Abbott, Bristol-Myers Squibb, Bayer AG, Boehringer Ingelheim, Baxter, F. Hoffmann-La Roche Ltd., H. Lundbeck A/S, Johnson and Johnson, Ligand Pharmaceuticals Incorporated, Novartis AG, Novo Nordisk A/S, Neurotech Pharmaceuticals, Inc., Oxurion NV, Pfizer, Inc., and Siemens Healthcare GmbH
Reasons to buy this Brain Hemorrhage Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Brain Hemorrhage Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Brain Hemorrhage Market
◘ Leading company profiles reveal details of key Brain Hemorrhage Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Brain Hemorrhage Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Brain Hemorrhage Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Brain Hemorrhage Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
https://www.coherentmarketinsights.com/promo/buynow/4659
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Reimbursement Scenario
- Mergers & Acquisitions
- Market Dynamics
- Global Brain Hemorrhage Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Global Brain Hemorrhage Market, By Drug Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Anti-hypertensive Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Anti-convulsants Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Hyperosmotic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others (others include Anti-epileptic Drugs, Anti-pyretic Drugs, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Brain Hemorrhage Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Brain Hemorrhage Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018–2028
- North America
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Region/Country, 2017 – 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Baxter
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Oxurion NV
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boehringer Ingelheim
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abbott
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bristol-Myers Squibb
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson and Johnson
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Neurotech Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Siemens Healthcare GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novo Nordisk A/S
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- H. Lundbeck A/S
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Ligand Pharmaceuticals Incorporated
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Baxter
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837